|
1
|
Dornan J, Taylor P and Walkinshaw MD:
Structures of immunophilins and their ligand complexes. Curr Top
Med Chem. 3:13922003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cheung-Flynn J, Roberts PJ, Riggs DL and
Smith DF: C-terminal sequences outside the tetratricopeptide repeat
domain of FKBP51 and FKBP52 cause differential binding to Hsp90. J
Biol Chem. 278:17388–17394. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cheung J and Smith DF: Molecular chaperone
interactions with steroid receptors: An update. Mol Endocrinol.
14:939–946. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Riggs DL, Roberts PJ, Chirillo SC,
Cheung-Flynn J, Prapapanich V, Ratajczak T, Gaber R, Picard D and
Smith DF: The Hsp90-binding peptidylprolyl isomerase FKBP52
potentiates glucocorticoid signaling in vivo. Embo J. 22:1158–1167.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tai PK, Maeda Y, Nakao K, Wakim NG,
Duhring JL and Faber LE: A 59-kilodalton protein associated with
progestin, estrogen, androgen, and glucocorticoid receptors.
Biochemistry. 25:5269–5275. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gallo LI, Ghini AA, Pilipuk Piwien G and
Galigniana MD: Differential recruitment of tetratricorpeptide
repeat domain immunophilins to the mineralocorticoid receptor
influences both heat-shock protein 90-dependent retrotransport and
hormone-dependent transcriptional activity. Biochemistry.
46:14044–14057. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brucker SY, Eisenbeis S, König J, Lamy M,
Salker MS, Zeng N, Seeger H, Henes M, Schöller D, Schönfisch B, et
al: Decidualization is impaired in endometrial stromal cells from
uterine rudiments in Mayer-Rokitansky-Küster-Hauser syndrome. Cell
Physiol Biochem. 41:1083–1097. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Leach DA, Trotta AP, Need EF, Risbridger
GP, Taylor RA and Buchanan G: The prognostic value of stromal
FK506-binding protein 1 and androgen receptor in prostate cancer
outcome. Prostate. 77:185–195. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hou J and Wang L: FKBP5 as a selection
biomarker for gemcitabine and Akt inhibitors in treatment of
pancreatic cancer. PLoS One. 7:e362522012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ni L, Yang CS, Gioeli D, Frierson H, Toft
DO and Paschal BM: FKBP51 promotes assembly of the Hsp90 chaperone
complex and regulates androgen receptor signaling in prostate
cancer cells. Mol Cell Biol. 30:1243–1253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang W, Cazacu S, Xiang C, Zenklusen JC,
Fine HA, Berens M, Armstrong B, Brodie C and Mikkelsen T: FK506
binding protein mediates glioma cell growth and sensitivity to
rapamycin treatment by regulating NF-kappaB signaling pathway.
Neoplasia. 10:235–243. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Solassol J, Mange A and Maudelonde T: FKBP
family proteins as promising new biomarkers for cancer. Curr Opin
Pharmacol. 11:320–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Storer CL, Dickey CA, Galigniana MD, Rein
T and Cox MB: FKBP51 and FKBP52 in signaling and disease. Trends
Endocrinol Metab. 22:481–490. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pyo JS, Kang G, Kim DH, Chae SW, Park C,
Kim K, Do Si, Lee HJ, Kim JH and Sohn JH: Activation of nuclear
factor-κB contributes to growth and aggressiveness of papillary
thyroid carcinoma. Pathol Res Pract. 209:228–232. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei L, Hui M, Sun D, Li W, Wang D, Zhang G
and Tan J: The relationship between BRAFV600E, NF-κB and TgAb
expression in papillary thyroid carcinoma. Pathol Res Pract.
213:183–188. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rotoli D, Morales M, Del Carmen Maeso M,
Del Pino García M, Morales A, Ávila J and Martín-Vasallo P:
Expression and localization of the immunophilin FKBP51 in
colorectal carcinomas and primary metastases, and alterations
following oxaliplatin-based chemotherapy. Oncol Lett. 12:1315–1322.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Romano S, D'Angelillo A, D'Arrigo P,
Staibano S, Greco A, Brunetti A, Scalvenzi M, Bisogni R, Scala I
and Romano MF: FKBP51 increases the tumour-promoter potential of
TGF-beta. Clin Transl Med. 3:12014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
D'Angelillo A, Staibano S, Russo M, Romano
MF and Romano S: Molecular aspects of FKBP51 that enable melanoma
dissemination. Curr Mol Pharmacol. 9:141–147. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song IH, Kim KR, Lim S, Kim SH and Sung
CO: Expression and prognostic significance of
epithelial-mesenchymal transition-related markers and phenotype in
serous ovarian cancer. Pathol Res Pract. 2018. View Article : Google Scholar
|
|
20
|
Ceresini G, Corcione L, Michiara M, Sgargi
P, Teresi G, Gilli A, Usberti E, Silini E and Ceda GP: Thyroid
cancer incidence by histological type and related variants in a
mildly iodine-deficient area of Northern Italy, 1998 to 2009.
Cancer. 118:5473–5480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jonklaas J, Murthy S, Liu D,
Klubo-Gwiezdzinska J, Krishnan J, Burman KD, Boyle L, Carrol N,
Felger E and Loh YP: Novel biomarker SYT12 may contribute to
predicting papillary thyroid cancer outcomes. Future Sci OA.
4:FSO2492017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Derwahl M and Nicula D: Estrogen and its
role in thyroid cancer. Endocr Relat Cancer. 21:T273–T283. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu J, Chen G, Meng XY, Liu ZH and Dong S:
Serum levels of sex hormones and expression of their receptors in
thyroid tissue in female patients with various types of thyroid
neoplasms. Pathol Res Pract. 210:830–835. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The Eighth Edition AJCC Cancer Staging Manual:
Continuing to build a bridge from a population-based to a more
“personalized” approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Haixia Guan, Zhongyan Shan, Xiaoyi Mi, et
al: 11 years of pathological analysis of thyroid cancer before and
after common salt iodization. J China Med Univer. 35:284–285.
2006.
|
|
26
|
Zhang Q, Liu SZ, Zhang Q, Guan YX, Chen QJ
and Zhu QY: Meta-analyses of association between BRAF(V600E)
mutation and clinicopathological features of papillary thyroid
carcinoma. Cell Physiol Biochem. 38:763–776. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen GG, Vlantis AC, Zeng Q and van
Hasselt CA: Regulation of cell growth by estrogen signaling and
potential targets in thyroid cancer. Curr Cancer Drug Targets.
8:367–377. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Choi MH, Moon JY, Cho SH, Chung BC and Lee
EJ: Metabolic alteration of urinary steroids in pre- and
post-menopausal women, and men with papillary thyroid carcinoma.
BMC Cancer. 11:3422011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Le Bihan S, Marsaud V, Mercier-Bodard C,
Baulieu EE, Mader S, White JH and Renoir JM: Calcium/calmodulin
kinase inhibitors and immunosuppressant macrolides rapamycin and
FK506 inhibit progestin-and glucocorticosteroid receptor-mediated
transcription in human breast cancer T47D cells. Mol Endocrinol.
12:986–1001. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rotoli D, Morales M, Ávila J, Maeso MDC,
García MDP, Mobasheri A and Martín-Vasallo P: Commitment of
scaffold proteins in the onco-biology of human colorectal cancer
and liver metastases after oxaliplatin-based chemotherapy. Int J
Mol Sci. 18:E8912017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luo K, Li Y, Yin Y, Li L, Wu C, Chen Y,
Nowsheen S, Hu Q, Zhang L, Lou Z and Yuan J: USP49 negatively
regulates tumorigenesis and chemoresistance through FKBP51-AKT
signaling. EMBO J. 36:1434–1446. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Loercher A, Lee TL, Ricker JL, Howard A,
Geoghegen J, Chen Z, Sunwoo JB, Sitcheran R, Chuang EY, Mitchell
JB, et al: Nuclear factor-kappaB is an important modulator of the
altered gene expression profile and malignant phenotype in squamous
cell carcinoma. Cancer Res. 64:6511–6523. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Romano S, Xiao Y, Nakaya M, D'Angelillo A,
Chang M, Jin J, Hausch F, Masullo M, Feng X, Romano MF and Sun SC:
FKBP51 employs both scaffold and isomerase functions to promote
NF-κB activation in melanoma. Nucleic Acids Res. 43:6983–6993.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li P, Zhang X, Wang L, Du L, Yang Y, Liu
T, Li C and Wang C: lncRNA HOTAIR contributes to 5FU resistance
through suppressing miR-218 and activating NF-κB/TS signaling in
colorectal cancer. Mol Ther Nucleic Acids. 8:356–369. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stechschulte LA, Hinds TD Jr, Ghanem SS,
Shou W, Najjar SM and Sanchez ER: FKBP51 reciprocally regulates GRα
and PPARγ activation via the Akt-p38 pathway. Mol Endocrinol.
28:1254–1264. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim JY, An HJ, Kim WH, Gwon MG, Gu H, Park
YY and Park KK: Anti-fibrotic effects of synthetic
oligodeoxynucleotide for TGF-β1 and smad in an animal model of
liver cirrhosis. Mol Ther Nucleic Acids. 8:250–263. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hu J, Zhu Q, Li PL, Wang W, Yi F and Li N:
Stem cell conditioned culture media attenuated albumin-induced
epithelial-mesenchymal transition in renal tubular cells. Cell
Physiol Biochem. 35:1719–1728. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Romano S, Staibano S, Greco A, Brunetti A,
Nappo G, Ilardi G, Martinelli R, Sorrentino A, Di Pace A, Mascolo
M, et al: FK506 binding protein 51 positively regulates melanoma
stemness and metastatic potential. Cell Death Dis. 4:e5782013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Srivastava SK, Bhardwaj A, Arora S, Tyagi
N, Singh AP, Carter JE, Scammell JG, Fodstad Ø and Singh S:
Interleukin-8 is a key mediator of FKBP51-induced melanoma growth,
angiogenesis and metastasis. Br J Cancer. 112:1772–1781. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Takaoka M, Ito S, Miki Y and Nakanishi A:
FKBP51 regulates cell motility and invasion via RhoA signaling.
Cancer Sci. 108:380–389. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ribeiro FR, Meireles AM, Rocha AS and
Teixeira MR: Conventional and molecular cytogenetics of human
non-medullary thyroid carcinoma: Characterization of eight cell
line models and review of the literature on clinical samples. BMC
Cancer. 8:3712008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ying Y, Qingwu L, Mingming X, Zhenju S,
Chaoyang T and Zhengang T: Emodin: One main ingredient of shufeng
jiedu capsule reverses chemoresistance of lung cancer cells through
inhibition of EMT. Cell Physiol Biochem. 42:1063–1072. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lv N, Shan Z, Gao Y, Guan H, Fan C, Wang H
and Teng W: Twist1 regulates the epithelial-mesenchymal transition
via the NF-κB pathway in papillary thyroid carcinoma. Endocrine.
51:469–477. 2016. View Article : Google Scholar : PubMed/NCBI
|
